Effects of single doses of rabeprazole 20 mg and esomeprazole 40 mg on 24-h intragastric pH in healthy subjects

Eur J Clin Pharmacol. 2006 Sep;62(9):685-91. doi: 10.1007/s00228-006-0148-5. Epub 2006 Jul 19.

Abstract

Objective: To compare antisecretory effects of single doses of rabeprazole and esomeprazole.

Methods: Open, randomised, 2-way crossover, clinical pharmacology study. 24 healthy subjects (10 men; mean age 26.2 y) received a single dose of rabeprazole 20 mg or esomeprazole 40 mg, with a 14-day 'washout'. Intragastric pH was recorded continuously from 24 h before to 24 h after dosing.

Results: Mean intragastric pH was higher after esomeprazole than rabeprazole during 0-5 h after dosing (P=0.0001); the reverse was true from 14-24 h (P=0.0002). Mean % time pH>3 and >4 was greater after esomeprazole than rabeprazole during 0-14 h (P=0.041 and 0.044), but the reverse was true during 14-24 h (P=0.0005 and 0.001). In the 0-24 h interval as a whole, there was no difference between treatments in mean pH or % time pH>3 or >4.

Conclusion: Single-dose rabeprazole 20 mg was as effective as esomeprazole 40 mg in increasing intragastric pH and maintaining pH>3 and >4, despite the 2-fold difference in dose.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / pharmacology*
  • Adult
  • Anti-Ulcer Agents / adverse effects
  • Anti-Ulcer Agents / pharmacology*
  • Area Under Curve
  • Cross-Over Studies
  • Esomeprazole / adverse effects
  • Esomeprazole / pharmacology*
  • Female
  • Gastric Acidity Determination*
  • Humans
  • Male
  • Rabeprazole

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Rabeprazole
  • Esomeprazole